111 related articles for article (PubMed ID: 21224623)
1. [Our experiences of XELOX + bevacizumab for two cases of metastatic sigmoid colon cancer].
Shioiri M; Kojima K; Yamamoto S; Watanabe Y; Mizutani M; Kamimura K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2511-3. PubMed ID: 21224623
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].
Uehara M; Sakamoto K; Konishi S; Hamasu S; Nishitai R; Manaka D
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1541-3. PubMed ID: 21918359
[TBL] [Abstract][Full Text] [Related]
3. [Our experience of the treatment with XELOX±Bevacizumab for unresectable advanced colorectal cancer].
Kashiwagi S; Maeda K; Fuyuhiro Y; Nagahara H; Kimura K; Amano R; Noda E; Kubo N; Tanaka H; Muguruma K; Yashiro M; Yamada N; Nakata B; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1936-8. PubMed ID: 22202244
[TBL] [Abstract][Full Text] [Related]
4. [A case of sigmoid colon cancer with a sigmoidovesical fistula treated with preoperative XELOX+bevacizumab therapy and urinary bladder-conserving surgery].
Miura T; Aoki K; Suto A; Yoshikawa T; Ikenaga SK; Kawashima H; Shibasaki I; Endo M
Gan To Kagaku Ryoho; 2014 Mar; 41(3):387-90. PubMed ID: 24743290
[TBL] [Abstract][Full Text] [Related]
5. [Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].
Sato A; Doi T; Boku N; Kato K; Komatsu Y; Yamaguchi K; Muro K; Hamamoto Y; Koizumi W; Mizunuma N; Takiuchi H
Gan To Kagaku Ryoho; 2011 Apr; 38(4):561-9. PubMed ID: 21498982
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative chemotherapy enabled radical resection of tumors in a patient with multiple liver metastases].
Shimizu K; Doi K; Ogawa K; Iwatsuki M; Tanaka H; Sugiyama S; Ogata K; Takamori H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1743-5. PubMed ID: 25731315
[TBL] [Abstract][Full Text] [Related]
7. [A case in which XELOX plus bevacizumab chemotherapy was effective in an elderly patient with heart failure and multiple liver metastases after sigmoidectomy].
Yoshida T; Matsui T; Aoyagi H; Hasegawa K; Kaneko J; Maejima S; Isogai J
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2011-3. PubMed ID: 24393996
[TBL] [Abstract][Full Text] [Related]
8. [A case in which chemotherapy-resistant sigmoid colon cancer was controlled effectively by radiotherapy and resection].
Sato N; Mukubo H; Nakanuma S; Yasui T; Kita I; Takanaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1996-8. PubMed ID: 24393991
[TBL] [Abstract][Full Text] [Related]
9. [A case of synchronous multiple liver metastasis of sigmoid colon cancer with a pathological complete response to combination chemotherapy of 5-FU/LV and bevacizumab].
Uegami S; Imamura Y; Daimaru Y; Nakamitsu A; Kouyama M; Kuwada A; Toge K; Taogoshi H; Yokoyama S; Fukuda Y
Gan To Kagaku Ryoho; 2011 Feb; 38(2):321-4. PubMed ID: 21368505
[TBL] [Abstract][Full Text] [Related]
10. [A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Ishida M; Miyazawa T; Ebe K; Koide N; Fujita N; Honma K; Ikarashi T
Gan To Kagaku Ryoho; 2013 Jan; 40(1):103-5. PubMed ID: 23306929
[TBL] [Abstract][Full Text] [Related]
11. [A case of sigmoid colon carcinoma accompanied with hydronephrosis caused by peritoneal dissemination and para-aortic lymph node metastases markedly responded to chemotherapy].
Hasegawa K; Matsumoto R; Yamada H; Kuroda T; Mamiya Y; Kon A
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2213-6. PubMed ID: 20037374
[TBL] [Abstract][Full Text] [Related]
12. [A case of Stage IV sigmoid colon cancer cured with radical combined modality therapy].
Babaya A; Fukunaga M; Yamamoto T; Oda K; Nakata K; Ohzato H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1956-8. PubMed ID: 24393978
[TBL] [Abstract][Full Text] [Related]
13. Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatment.
Weihrauch MR; Stippel D; Fries JW; Arnold D; Bovenschulte H; Coutelle O; Hacker U
Onkologie; 2008 Sep; 31(8-9):464-7. PubMed ID: 18787354
[TBL] [Abstract][Full Text] [Related]
14. [A patient with sigmoid colon cancer( cStage IV) who responded to preoperative chemotherapy with mFOLFOX6 plus bevacizumab and was subsequently able to undergo a radical operation].
Kaneko J; Aoyagi H; Yoshida T; Iwata N; Hasegawa K; Yamamoto H; Oshida K; Takahata T; Maejima S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2204-6. PubMed ID: 23268024
[TBL] [Abstract][Full Text] [Related]
15. [XELOX plus Bevacizumab Chemotherapy for a Patient with Postoperative Recurrence of Colorectal Cancer Under Hemodialysis for Chronic Renal Failure].
Takeda T; Miyake M; Tanaka K; Uemura M; Ikeda M; Maeda S; Yamamoto K; Hama N; Nishikawa K; Miyamoto A; Miyazaki M; Hirao M; Nakamori S; Sekimoto M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1594-6. PubMed ID: 26805107
[TBL] [Abstract][Full Text] [Related]
16. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
Dohn LH; Jensen BV; Larsen FO
Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
[No Abstract] [Full Text] [Related]
17. [A case of long-term survival due to combined modality therapy for liver metastasis of colon cancer].
Hasegawa H; Hashimoto T; Nakamura T; Kitagawa M; Kudo K; Shoji F; Kabashima A; Teramoto S; Kitamura M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2234-6. PubMed ID: 23268034
[TBL] [Abstract][Full Text] [Related]
18. [A case of pathologically by complete response in advanced sigmoid colon cancer with multiple metastases of lung and Liver, left hydronephrosis after chemotherapy including bevacizumab/FOLFOX6].
Kubo H; Nishiyama M; Tada K; Miyahara M; Hasegawa H; Yamashita Y
Gan To Kagaku Ryoho; 2012 Jun; 39(6):987-9. PubMed ID: 22705699
[TBL] [Abstract][Full Text] [Related]
19. Virchow lymph node metastatic recurrence of sigmoid colon cancer with severe lymph node metastases successfully treated using systemic chemotherapy combined with radiotherapy.
Ohchi T; Akagi Y; Kinugasa T; Ishibashi Y; Tanaka N; Fujino S; Kibe S; Yuge K; Sasatomi T; Mizobe T; Oka Y; Hong KD; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2935-40. PubMed ID: 23780983
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer.
Vrdoljak E; Omrčen T; Boban M; Hrabar A
Anticancer Drugs; 2011 Feb; 22(2):191-7. PubMed ID: 21057306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
